Melissa Hollo: Intravenous Iron Shows Better Results Than Oral Iron in Pregnancy
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared Robert Brown’s post on LinkedIn, adding:
”A well-done study in Obstetrics and Gynecology reinforcing what many of us are seeing in practice:
Intravenous ferumoxytol isn’t just an alternative to oral iron in pregnancy, it’s more effective.
This randomized trial shows:
- Significantly greater increases in hemoglobin with IV ferumoxytol vs oral ferrous sulfate
- Meaningful improvements in ferritin and iron indices
- Better correction of anemia by the time of delivery
For a condition as common, and consequential, as iron deficiency anemia in pregnancy, this matters.
We cannot continue to rely on oral iron alone when:
- Absorption is variable
- Tolerability limits adherence
- Time to correction is often too slow for the peripartum window
This is exactly why earlier identification and more effective treatment pathways are critical.
The takeaway is clear:
If we are serious about improving maternal outcomes, IV iron should be considered sooner, not later.
Learn how we’re supporting earlier maternal risk detection.”
Robert Brown, Academic Obstetrician, shared a post on LinkedIn about a recent article by Irogue I Igbinosa, published in Obstetrics and Gynecology։
”IV iron versus oral iron pregnancy anemia.”
Title: Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy
A Randomized Controlled Trial
Authors: Irogue I Igbinosa, Stephanie A Leonard, Ijeoma Iwekaogwu, Elizabeth B Sherwin, Caroline Berube, Deirdre J Lyell
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 18:15Chuhan Dong: Presenting My Research on Antibody-Mediated RBC Clearance at Canadian Blood Services
-
Jun 7, 2026, 18:11Abdul Mannan: Pencil Cells in IDA – Why Most, but Not All Cases Show Them
-
Jun 7, 2026, 16:12Amr Mohamed: Common Types of Anemia
-
Jun 7, 2026, 15:50Venkateshwarlu Bairi: AVEVA Hyderabad Supports Children Living with Thalassemia and Sickle Cell Conditions
-
Jun 7, 2026, 15:48José Antonio García Erce: Hemochromatosis and Blood Donation
-
Jun 7, 2026, 15:29Marc Scherlinger: Uncovering the Immuno-Inflammatory Functions of Platelets at EULAR 2026
-
Jun 7, 2026, 15:18Huyen Nguyen: Highlights from the NCCN Cancer-Associated Venous Thromboembolic Disease Guidelines
-
Jun 7, 2026, 14:35Erica Wood: WHO Launches Landmark Action Framework to Secure Safe and Equitable Blood Supply Worldwide
-
Jun 7, 2026, 14:27Jorge Lima: Amniotic Fluid Embolism and Its Impact on Maternal and Perinatal Outcomes